跳转至内容
Merck
CN
所有图片(1)

文件

安全信息

GE17-5474-02

MabSelect SuRe LX

Cytiva 17-5474-02, pack of 200 mL

登录查看公司和协议定价

UNSPSC代码:
41106500
NACRES:
NA.56

ligand

alkali-stabilized protein A-derived (E. coli)

保质期

Please be aware this product may be shipped 90 days before the expiration date. For more information on the batch specific expiration date, please contact technical service.

包装

pack of 200 mL

制造商/商品名称

Cytiva 17-5474-02

储存条件

(20% Ehtanol)

基质

highly cross-linked agarose

平均零件尺寸

85 μm (d₅₀v is the median particle size of the cumulative volume distribution)

cleaning in place

2-13.7(pH below 3 is sometimes required to elute strongly bound IgG species. However, protein ligands may hydrolyze at very low pH.)

working range

3-12(pH below 3 is sometimes required to elute strongly bound IgG species. However, protein ligands may hydrolyze at very low pH.)

容量

~60 mg binding capacity(human IgG/ml medium. Determined at 10% breakthrough by frontal analysis at a mobile phase velocity of 100 cm/h in a column with a bed height of 20 cm, i.e. residence time is 6.0 min.)

适用性

suitable for bioprocess medium

储存温度

2-8°C

相关类别

一般描述

MabSelect SuRe LX is a protein A affinity medium with very high dynamic binding capacity at extended residence times and is developed for high titer antibody processes. Alkali tolerance, high capacity and low ligand leakage in combination with the rigid base matric makes MabSelect SuRe LX highly suitable for purification of monoclonal anitbodies for clinical applications.

MabSelect SuRe LX is a member of the MabSelect family of affinity chromatography media for the capture of monoclonal antibodies (MAbs) at process scale. MabSelect SuRe LX shares features and benefits of MabSelect and MabSelect SuRe such as a rigid, high-flow agarose matrix that ensures excellent pressure/flow properties, low non-specific binding that leads to low impurity levels in the eluate pool, and an oriented ligand coupling for optimal binding capacity. It also features the same alkali-tolerant rProtein A ligand as MabSelect SuRe. This ligand provides greater stability than conventional protein A-based media in the alkaline conditions used in cleaning-in-place (CIP) and sanitization protocols. The enhanced alkali stability of MabSelect SuRe improves process economy and product quality; cleaning can be performed with cost-effective reagents such as sodium hydroxide eliminating the need for expensive and hazardous cleaning agents such as Gua-HCl. Process economy is also improved by the increased dynamic binding capacity of MabSelect SuRe LX.

Just as for MabSelect SuRe, the novel ligand construct of MabSelect SuRe LX has been proven to have an increased stability towards proteases. Therefore, the level of leakage of the MabSelect SuRe LX ligand during elution is low.

MabSelect SuRe has been demonstrated to give generic elution conditions for different monoclonal antibodies which can be applied also to MabSelect SURe LX since it utilizes the same ligand. This is an advantage when designing generic purification platform processes. The feature is also correlated to the construction of the MabSelect SuRe ligand.

MabSelect SuRe LX is available in a range of different bulk pack sizes and convenient pre-packed formats for easy scale-up and process development. As member of the BioProcess media range, MabSelect SuRe meets industrial demands with security of supply and comprehensive technical and regulatory support.

特点和优势

  • Novel, alkali-tolerant rProtein A ligand withstands rigorous CIP and sanitization procedures with 0.1 to 0.5 M NaOH.
  • Reduces the risk of product contamination and carryover
  • Improves performance and reduces overall costs
  • High dynamic binding capacity (DBC) for high titer cultures reduces process time and amount of medium used
  • Generic elution profile for different monoclonal antibodies enables platform approach to purification
  • High-flow agarose matrix allows the processing of large feed volumes

分析说明

To view the Certificate of Analysis for this product, please visit www.cytiva.com.

法律信息

Free MabSelect SuRe Ligand
"MabSelect SuRe Ligand Restricted License" and "Cys-rProtein A Ligand Restricted License" are protected by the following patents and equivalent patents and patent applications in other countries: US 6,399,750 and EP 1123389. A free, non-transferable limited license to use this product for internal analytical purposes only accompanies the purchase of the product from a Cytiva company and its licensed distributors. Any other use will require a separate license from a Cytiva company.
MabSelect is a trademark of Cytiva
MabSelect SuRe is a trademark of Cytiva
SuRe is a trademark of Cytiva

象形图

Flame

警示用语:

Warning

危险声明

法规信息

新产品

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

商品

Description of viral clearance using Capto adhere from Cytiva.

Capto adhere from Cytiva is a multimodal strong anion exchanger for BioProcess applications.

This page describes the difference between bind/elute and flowthrough modes in multimodal chromatography using Cytiva products.

This page describes the maintenance of media and storage conditions for multimodal chromatography using Cytiva products.

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门